基本信息
浏览量:280
职业迁徙
个人简介
Over 20 years experiences in drug hunting, especially on GPCR targets involved in CNS, endocrine and metabolic diseases with proven track record of success as medicinal chemist and as a leader to discover and deliver multiple clinical compounds including elagolix, a FDA approved drug, paltusotine, a clinic candidate in Phase III study, CRN04894 and CRN04777 in Phase I studies; skillful for managing multidisciplinary teams with strong background of medicinal chemistry and great nature instinct on designing small molecules drug candidates; experienced in oversea outsourcing management; proficient in communicating with collaborators and in writing manuscripts.
研究兴趣
论文共 63 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ACS MEDICINAL CHEMISTRY LETTERSno. 4 (2024): 478-485
引用0浏览0引用
0
0
加载更多
作者统计
#Papers: 100
#Citation: 2178
H-Index: 29
G-Index: 43
Sociability: 6
Diversity: 3
Activity: 12
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn